Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye.

Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye. Abstract Text:

Sphingosine-1-phosphate (S1P) is a pleiotropic lysolipid that has recently been implicated in the regulation of tissue fibrosis. However, the fibrogenic potential of S1P in the eye has not previously been investigated. In the current study, we evaluated cells from the anterior and posterior segments of the eye for the presence of S1P and their potential ability to produce and respond to S1P. In addition, we investigated the regulatory role of S1P as a mediator of proliferation, cellular transformation and pro-fibrotic protein expression in human retinal pigmented epithelial cells. Expression of S1P receptors and sphingosine kinases (the enzymes that produce S1P) was examined using RT-PCR, and intracellular localization of S1P was examined using immunoblotting, immunohistochemistry and ELISA in primary human retinal pigmented epithelial (RPE) cells, primary human conjunctival fibroblasts (ConF), and primary human corneal fibroblasts (CF). RPE cell proliferation was determined using an MTT-based cell proliferation assay, and RPE myofibroblast transformation, collagen type I production and profibrotic protein expression were assessed using immunofluorescence, ELISA and immunoblot. S1P(1-3, 5) receptors and sphingosine kinases 1 and 2 were expressed and intracellular pools of S1P were detected in RPE cells, ConF and CF. S1P stimulated RPE cell proliferation in a dose- and time-dependent manner. S1P induced myofibroblast transformation of RPE cells, as indicated by increased alpha-smooth muscle actin (alpha-SMA) expression and its incorporation into prominent stress fibers, and promoted collagen type I production. S1P stimulated the expression of plasminogen activator inhibitor-1 (PAI-1) and heat shock protein 47 (HSP47), two proteins that are linked to increased tissue fibrosis. Combined, these data demonstrate that RPE cells, ConF and CF from the human eye not only have the molecular ability to produce and respond to S1P, but also contain S1P. Furthermore, S1P promotes proliferation, myofibroblast transformation, collagen production and pro-fibrotic protein expression by human RPE cells. These data suggest that S1P is a previously unrecognized mediator of profibrotic cellular function and signaling in the eye.

Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Experimental eye research

VOLUME: 87

Page Numbers: 367-75

Journal Abbreviation: Exp. Eye Res.

ISSN: 1096-0007

DAY: 18

MONTH: 07

YEAR: 2008

Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370707

Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye.

AFFILIATION: Lpath Inc., San Diego, CA 92121, USA. jswaney@lpath.com

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Exp Eye Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Sphingosine-1-phosphate S1P is a novel fibrotic mediator in the eye Related Publications

• A women with ulcerating, painful skin lesions.
• An analysis of needs for respiratory therapists in northeast ohio and development of strategies to meet increased recruitment demands.
• Antitrypsin deficiency vs Gianotti-Crosti syndrome.
• Association between Randall's plaque and calcifying nanoparticles.
• Changing paradigms in the surgical and medical management of acromegaly.
• Endoscopic management of obstructive complications in ureterosigmoidostomy.
• Exploring Leadership Competencies in Established and Aspiring Physician Leaders: An Interview-based Study.
• Isolated familial benign chronic pemphigus.
• Laboratory Evaluation of the Vortran Automatic Resuscitator Model RTM.
• Laparoscopic nephrectomy, ex vivo partial nephrectomy followed by allograft renal transplantation.
• Long-term outcomes and late complications of laparoscopic nephrectomy with renal autotransplantation.
• Modern trends in British psychiatry.
• Oral calcium supplementation associated with decreased likelihood of nephrolithiasis prior to surgery for hyperparathyroidism.
• Percutaneous management of stones in transplanted kidneys.
• Quality control for spirometry in large epidemiologic studies: "breathing quality" into our work.
• Social health and psychiatric service.
• Social work and the ex-serviceman; the psychiatric problem.
• Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye.
• Symptomatic perirenal serous cysts of müllerian origin mimicking renal cysts on CT.
• The authors respond:.
• The utility of spirometry in diagnosing pulmonary restriction.
• Therapy for alpha(1)-Antitrypsin Deficiency: Pharmacology and Clinical Recommendations.
• Urinary citrate levels do not correlate with urinary pH in patients with urinary stone formation.
• Why we are not morally required to select the best children: a response to savulescu.
• [Not Available.]